AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
about
Carnosinases, their substrates and diseasesEdaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cellsImmunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitusSterile inflammation: sensing and reacting to damageGlycation of extracellular matrix proteins impairs migration of immune cells.Differential effects of glycation on protein aggregation and amyloid formation.Brain type carnosinase in dementia: a pilot study.Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cellsPyridoxamine: the many virtues of a maillard reaction inhibitor.Does chronic glycolysis accelerate aging? Could this explain how dietary restriction works?Glycation accelerates fibrillization of the amyloidogenic W7FW14F apomyoglobinInvolvement of Maillard reactions in Alzheimer disease.Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.Aldehydes and disturbance of carbohydrate metabolism: some consequences and possible approaches to its normalization.Impact of glucose levels on advanced glycation end products in hemodialysis.Advanced glycation endproducts and their pathogenic roles in neurological disorders.Tackling the aging process with bio-molecules: a possible role for caloric restriction, food-derived nutrients, vitamins, amino acids, peptides, and minerals.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs.The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.Glycation of Liver Cystatin: Implication on its Structure and Function.Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts.Optimizing Carnosine Containing Extract Preparation from Chicken Breast for Anti-glycating agents.The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's diseaseTumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.Burkholderia cepacia lipase: A versatile catalyst in synthesis reactions.Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?
P2860
Q26829095-824F5E30-E5AC-482A-880B-C1A7075D8B04Q27322912-DB1B2029-98DB-4215-BAAE-044703CDDCC6Q28269188-EA7E0B3A-CDC3-4042-A23F-2DDC2E72FF40Q29620014-3683CA81-4290-4BD3-98B9-9163DC85824AQ30317492-83F4D900-9DA4-4D68-879F-D9A850A69333Q30374807-1DD70EC2-0D17-4F15-B129-3CA5C9D12696Q33305023-E75B6497-A1EF-4582-BC76-14E7FAFCD7DAQ33409132-4A91CABB-0047-47E7-B279-91DEEF36B516Q34436025-67641584-7CFF-4BB8-AD2A-DB17941F64F3Q34542350-DB11F779-20CC-437E-9AC5-2D286B0DA7C6Q35063787-FA323007-876D-4283-A9FD-4CCB0B6843AAQ35164047-A594303C-55BA-4DD6-8F7B-19CB276D606EQ36057624-2B893FC4-EC40-4609-A5D9-3674EC83C7A8Q36844820-0D6F4D7D-C3B0-4AEE-B800-BA2D7150BDB0Q36852110-109A1FC8-BFEF-42CD-B395-93E1E7CD01B2Q37800424-C4525EBB-EE0A-4874-934E-DEA196E93DD9Q38085661-8EA3EDB4-C4FE-4634-9047-63A9F1A14804Q38096444-8E0361D2-C2BB-4ABC-8007-D5D3C911A403Q38229613-C5AA8AA4-1202-4BD3-ACAD-2BB662CDB1ECQ38241689-8FF79D9C-8A1B-4588-AE31-AB0750ACFF82Q39649360-17A00F58-7B73-49A4-9213-FF7C7E36665EQ39694381-03BC5891-0D7D-4291-A1AD-E66B3D0C42C1Q41115517-2CE6F1E9-0195-442B-B314-EA17A8F9221AQ41852765-0C417EF1-754B-456A-966C-C19CD014ED70Q42155901-8D3AE7BC-A95F-4B50-B21F-FC69BF376BDAQ42157623-27BC54FF-D9D6-489D-9D02-B3ADFF2F23C3Q45184960-F9752779-8581-45E3-8A24-457E62D79645Q46811176-EB7CB96D-40C7-4E80-9511-30D241B840FCQ48300788-05C4FD6F-E340-4D22-A12B-F7874F42FDACQ53244774-AE94158C-B9D1-4983-85E3-5B22F3D808B3
P2860
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@ast
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@en
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@nl
type
label
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@ast
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@en
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@nl
prefLabel
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@ast
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@en
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@nl
P2093
P356
P1433
P1476
AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
@en
P2093
Dukic-Stefanovic S
Riederer P
Schinzel R
P2888
P356
10.1023/A:1010052800347
P577
2001-01-01T00:00:00Z
P6179
1019356837